Omerna Biosolutions
PrivateCompany Overview
Omerna Biosolutions is a biotechnology company that develops a platform for the oral delivery of RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omerna Biosolutions Comparables
Compare Omerna Biosolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agriterna | 81% | |
| Apolo Biotech | 81% | |
| SenseUP | 79% |
Omerna Biosolutions Funding Rounds
Historical fundraising activity
Omerna Biosolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Institute of Innovation and Technology | Accelerator, Grant |
| Israel Innovation Authority | Accelerator, Grant |
| InNegev | Grant, Accelerator |
Omerna Biosolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Omerna Biosolutions's valuation, stock price, and market status.
Is Omerna Biosolutions a public or private company?
Omerna Biosolutions is a private company.
What is the current stock price of Omerna Biosolutions?
Omerna Biosolutions is a private company, so its shares have no public market price. Caplight tracks Omerna Biosolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omerna Biosolutions worth (valuation)?
Valuation information for Omerna Biosolutions is not publicly available.
Can I buy Omerna Biosolutions stock?
Omerna Biosolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omerna Biosolutions's last funding round?
Funding round information for Omerna Biosolutions is not publicly available.
Who are the main investors in Omerna Biosolutions?
Key investors in Omerna Biosolutions include InNegev.
Will Omerna Biosolutions IPO soon?
No public IPO plans have been announced for Omerna Biosolutions.
How can I track Omerna Biosolutions secondary market activity?
Caplight tracks bids, offers, and trades in Omerna Biosolutions's shares on secondary markets.